Back to search
FDAFDA · Food and drugs·Recall number D-105-2013

Cymevene 500 mg Powder for Infusion, (ganciclovir), 50 mg/mL ganciclovir (reconstructed), Rx only, 10 mL vials, Roche Products Limited, Welwyn Garden City, AL7 1TW, United Kingdom

Published January 2, 2013 · Recall initiated: September 5, 2012

Summary

FDA records drug Class II recall D-105-2013, published January 2, 2013 and initiated September 5, 2012. Recalling firm: F. Hoffmann-LaRoche Ltd.; Status: Terminated; Reported quantity: 42010 vials; Lot: bulk lot N0019, Expiration Date: 11 2014 Warennummer: 10131968 Chargennummer:NXXXX 2000609D Finished product Lot N0019B01-N0019B12. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; container closure issues with the bulk batch.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
F. Hoffmann-LaRoche Ltd.
Distributor
No product distributed in the USA. Bulk product distributed to Switzerland, with further distribution in Europe, Scandinavia, Korea.
Lot
bulk lot N0019, Expiration Date: 11 2014 Warennummer: 10131968 Chargennummer:NXXXX 2000609D Finished product Lot N0019B01-N0019B12
Risk classification
Class II
Area (FDA)
drug
Country
Switzerland

Related recalls

Questions about this recall

Was Cymevene 500 mg Powder for Infusion, (ganciclovir), 50 mg/mL ganciclovir (reconstructed), Rx only, 10 mL vials, Roche Products Limited, Welwyn Garden City, AL7 1TW, United Kingdom recalled?

Yes. FDA published recall D-105-2013 on January 2, 2013. Reported hazard: Lack of Assurance of Sterility; container closure issues with the bulk batch.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit